PAPER Pakhomov SV, Kaiser EA, Boley DL, Marino SE, Knopman DS, Birnbaum AK
SEARCH RESULTS
331397 RESULTS
PAPER Batelli S, Peverelli E, Rodilossi S, Forloni G, Albani D
Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).
Neuroscience. 2011 Nov 10;195:128-37. PubMed: 21906659PAPER Li SX, Huang S, Bren N, Noridomi K, Dellisanti CD, Sine SM, Chen L
Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonist.
Nat Neurosci. 2011 Oct;14(10):1253-9. PubMed: 21909087PAPER Pasinetti GM, Wang J, Marambaud P, Ferruzzi M, Gregor P, Knable LA, Ho L
Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.
Exp Neurol. 2011 Nov;232(1):1-6. PubMed: 21907197PAPER Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L
Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
Brain. 2011 Sep;134(Pt 9):2722-35. PubMed: 21908876PAPER Kaneb HM, Sharp PS, Rahmani-Kondori N, Wells DJ
Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice.
PLoS One. 2011;6(9):e24189. PubMed: 21909419PAPER Chapman TR, Barrientos RM, Ahrendsen JT, Hoover JM, Maier SF, Patterson SL
Aging and infection reduce expression of specific brain-derived neurotrophic factor mRNAs in hippocampus.
Neurobiol Aging. 2011 Sep 8; PubMed: 21907460PAPER Kim J, Bordiuk OL, Ferrante RJ
Experimental models of HD and reflection on therapeutic strategies.
Int Rev Neurobiol. 2011;98:419-81. PubMed: 21907096PAPER Schulte J, Sepp KJ, Wu C, Hong P, Littleton JT
High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model.
PLoS One. 2011;6(8):e23841. PubMed: 21909362PAPER Enunlu I, Ozansoy M, Basak AN
Alfa-class prefoldin protein UXT is a novel interacting partner of Amyotrophic Lateral Sclerosis 2 (Als2) protein.
Biochem Biophys Res Commun. 2011 Sep 30;413(3):471-5. PubMed: 21907703PAPER Lee JE, Kang JS, Shin IC, Lee SJ, Hyun DH, Lee KS, Koh HC
Fluazinam-induced apoptosis of SH-SY5Y cells is mediated by p53 and Bcl-2 family proteins.
Neurotoxicology. 2011 Dec;32(6):702-10. PubMed: 21907236PAPER Rami A, Kim M, Niquet J, Langhagen A
Alterations in the Expression of the Anti-Apoptotic Factor HAX-1 upon Seizures-Induced Hippocampal Injury in the Neonatal Rat Brain.
Neurochem Res. 2012 Jan;37(1):116-25. PubMed: 21909957PAPER Duclot F, Lapierre M, Fritsch S, White R, Parker MG, Maurice T, Cavaillès V
Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression.
Genes Brain Behav. 2012 Feb;11(1):69-78. PubMed: 21906262PAPER Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E, Troakes C, Al-Sarraj S, King A, Borroni B, Clarkson MJ, Ourselin S, Holton JL, Fox NC, Revesz T, Rossor MN, Warren JD
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.
Brain. 2011 Sep;134(Pt 9):2565-81. PubMed: 21908872PAPER Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, Kirby J, Shaw PJ
Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis.
Brain. 2011 Sep;134(Pt 9):2627-41. PubMed: 21908873Current Filters
No filters selected